<p>We talk the future of psychedelics: &nbsp;decriminalization &amp; legalization. Biotech &amp; Pharma research, Compass Pathways (CMPS), Mind Medicine (MMED / MMEDF), Field Trip Health (FTRP) on substances like LSD, Psilocybin, Ibogaine, etc.</p>

3: MindMed Deep Dive. JR Rahn, LSD, Nasdaq Uplisting, Pump and Dump or To the Moon?

The Integration Conversation covers the emerging psychedelic industry. Watch as Hedge Fund veteran and psychedelic enthusiast Brom interviews psychedelic CEOs, performs in-depth analysis of psychedelic companies, and discusses the implications of psychedelics on our society. 

Prior to starting the Integration Conversation, Brom spent 7 years as a quant at multiple hedge funds.  Brom is a CFA charterholder and holds an MS in CS with a focus on Machine Learning from Georgia Tech.  In addition to running the Integration Conversation, Brom is focused on angel investing in psychedelic startups.